Risk of Primary Gastrointestinal Lymphoma in Patients With Inflammatory Conditions Exposed to Tumor Necrosis Factor Alpha Inhibitors and Immunomodulators: A Case-Control Study.
Manuel B Braga NetoJason NasserXiao Xing Iris WangWilliam Scott HarmsenLaura E RaffalsMichael CamilleriVictor G ChedidPublished in: Crohn's & colitis 360 (2024)
TNFI therapy was not associated with increased risk for PGIL unless used in combination with thiopurines and with every switch to a different TNFI.